Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Damien Montamat-Sicotte is active.

Publication


Featured researches published by Damien Montamat-Sicotte.


Journal of Experimental Medicine | 2003

Characterization of the CD4+ T Cell Response to Epstein-Barr Virus during Primary and Persistent Infection

Elisabeth Amyes; Chris Hatton; Damien Montamat-Sicotte; Nancy H. Gudgeon; Alan B. Rickinson; Andrew J. McMichael; Margaret F. C. Callan

The CD8+ T cell response to Epstein-Barr virus (EBV) is well characterized. Much less is known about the evolution of the CD4+ T cell response. Here we show that EBV stimulates a primary burst of effector CD4+ T cells and this is followed by a period of down-regulation. A small population of EBV-specific effector CD4+ T cells survives during the lifelong persistent phase of infection. The EBV-specific effector CD4+ T cells accumulate within a CD27+ CD28+ differentiation compartment during primary infection and remain enriched within this compartment throughout the persistent phase of infection. Analysis of CD4+ T cell responses to individual epitopes from EBV latent and lytic cycle proteins confirms the observation that the majority of the effector cells express both CD27 and CD28, although CD4+ T cells specific for lytic cycle antigens have a greater tendency to express CD45RA than those specific for the latent antigens. In clear contrast, effector CD4+ T cells specific for cytomegalovirus (CMV) accumulate within the CD27− CD28+ and CD27− CD28− compartments. There are striking parallels in terms of the differentiation of CD8+ T cells specific for EBV and CMV. The results challenge current ideas on the definition of memory subsets.


PLOS ONE | 2010

Enumeration of functional T-cell subsets by fluorescence-immunospot defines signatures of pathogen burden in tuberculosis.

Rosalyn Casey; Deena Blumenkrantz; Kerry A. Millington; Damien Montamat-Sicotte; Onn Min Kon; Melissa Wickremasinghe; Samuel Bremang; Murphy Magtoto; Saranya Sridhar; David Connell; Ajit Lalvani

Background IFN-γ and IL-2 cytokine-profiles define three functional T-cell subsets which may correlate with pathogen load in chronic intracellular infections. We therefore investigated the feasibility of the immunospot platform to rapidly enumerate T-cell subsets by single-cell IFN-γ/IL-2 cytokine-profiling and establish whether immunospot-based T-cell signatures distinguish different clinical stages of human tuberculosis infection. Methods We used fluorophore-labelled anti-IFN-γ and anti-IL-2 antibodies with digital overlay of spatially-mapped colour-filtered images to enumerate dual and single cytokine-secreting M. tuberculosis antigen-specific T-cells in tuberculosis patients and in latent tuberculosis infection (LTBI). We validated results against established measures of cytokine-secreting T-cells. Results Fluorescence-immunospot correlated closely with single-cytokine enzyme-linked-immunospot for IFN-γ-secreting T-cells and IL-2-secreting T-cells and flow-cytometry-based detection of dual IFN-γ/IL-2-secreting T-cells. The untreated tuberculosis signature was dominated by IFN-γ-only-secreting T-cells which shifted consistently in longitudinally-followed patients during treatment to a signature dominated by dual IFN-γ/IL-2-secreting T-cells in treated patients. The LTBI signature differed from active tuberculosis, with higher proportions of IL-2-only and IFN-γ/IL-2-secreting T-cells and lower proportions of IFN-γ-only-secreting T-cells. Conclusions Fluorescence-immunospot is a quantitative, accurate measure of functional T-cell subsets; identification of cytokine-signatures of pathogen burden, distinct clinical stages of M. tuberculosis infection and long-term immune containment suggests application for treatment monitoring and vaccine evaluation.


Journal of Clinical Investigation | 2011

A mycolic acid–specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infection

Damien Montamat-Sicotte; Kerry A. Millington; Carrie R. Willcox; Suzie Hingley-Wilson; Sarah Hackforth; John A. Innes; Onn Min Kon; David A. Lammas; David E. Minnikin; Gurdyal S. Besra; Benjamin E. Willcox; Ajit Lalvani

Current tuberculosis (TB) vaccine strategies are largely aimed at activating conventional T cell responses to mycobacterial protein antigens. However, the lipid-rich cell wall of Mycobacterium tuberculosis (M. tuberculosis) is essential for pathogenicity and provides targets for unconventional T cell recognition. Group 1 CD1-restricted T cells recognize mycobacterial lipids, but their function in human TB is unclear and their ability to establish memory is unknown. Here, we characterized T cells specific for mycolic acid (MA), the predominant mycobacterial cell wall lipid and key virulence factor, in patients with active TB infection. MA-specific T cells were predominant in TB patients at diagnosis, but were absent in uninfected bacillus Calmette-Guérin-vaccinated (BCG-vaccinated) controls. These T cells were CD1b restricted, detectable in blood and disease sites, produced both IFN-γ and IL-2, and exhibited effector and central memory phenotypes. MA-specific responses contracted markedly with declining pathogen burden and, in patients followed longitudinally, exhibited recall expansion upon antigen reencounter in vitro long after successful treatment, indicative of lipid-specific immunological memory. T cell recognition of MA is therefore a significant component of the acute adaptive and memory immune response in TB, suggesting that mycobacterial lipids may be promising targets for improved TB vaccines.


The Journal of Infectious Diseases | 2013

T-Cell Immunophenotyping Distinguishes Active From Latent Tuberculosis

Katrina Pollock; Hilary Whitworth; Damien Montamat-Sicotte; Lisa Grass; Graham S. Cooke; Moses S. Kapembwa; Onn M. Kon; Robert D. Sampson; Graham P. Taylor; Ajit Lalvani

Background. Changes in the phenotype and function of Mycobacterium tuberculosis (M. tuberculosis)-specific CD4+ and CD8+ T-cell subsets in response to stage of infection may allow discrimination between active tuberculosis and latent tuberculosis infection. Methods. A prospective comparison of M. tuberculosis-specific cellular immunity in subjects with active tuberculosis and latent tuberculosis infection, with and without human immunodeficiency virus (HIV) coinfection. Polychromatic flow cytometry was used to measure CD4+ and CD8+ T-cell subset phenotype and secretion of interferon γ (IFN-γ), interleukin 2 (IL-2), and tumor necrosis factor α (TNF-α). Results. Frequencies of CD4+ and CD8+ cells secreting IFN-γ-only, TNF-α-only and dual IFN-γ/TNF-α were greater in active tuberculosis vs latent tuberculosis infection. All M. tuberculosis-specific CD4+ subsets, with the exception of IL-2-only cells, switched from central to effector memory phenotype in active tuberculosis vs latent tuberculosis infection, accompanied by a reduction in IL-7 receptor α (CD127) expression. The frequency of PPD-specific CD4+ TNF-α-only-secreting T cells with an effector phenotype accurately distinguished active tuberculosis from latent tuberculosis infection with an area under the curve of 0.99, substantially more discriminatory than measurement of function alone. Conclusions. Combined measurement of T-cell phenotype and function defines a highly discriminatory biomarker of tuberculosis disease activity. Unlocking the diagnostic and monitoring potential of this combined approach now requires validation in large-scale prospective studies.


The Journal of Infectious Diseases | 2005

Virus-Specific Cytotoxic T Lymphocytes Differentially Express Cell-Surface Leukocyte Immunoglobulin-Like Receptor–1, an Inhibitory Receptor for Class I Major Histocompatibility Complex Molecules

Richard D Antrobus; Naeem Khan; Andrew D. Hislop; Damien Montamat-Sicotte; Lee I. Garner; Alan B. Rickinson; Paul Moss; Benjamin E. Willcox

Leukocyte immunoglobulin-like receptor-1 (LIR-1) is an inhibitory receptor that negatively regulates T cell effector functions after interaction with host class I major histocompatibility complex molecules and, additionally, binds to UL18, a human cytomegalovirus (HCMV)-encoded class I homologue. Here, we demonstrate that virus-specific cytotoxic T lymphocytes (CTLs) differentially express LIR-1, with high frequencies of expression on HCMV-specific CD8+ T cells and intermediate and low frequencies of expression on influenza virus-specific and Epstein-Barr virus (EBV)-specific CTLs, respectively. Expression of LIR-1 was dependent on CTL-antigen specificity and was associated with a differentiated effector memory phenotype, as demonstrated by decreased expression of CD28 and increased expression of CD57. During primary HCMV and EBV infections, expression of LIR-1 on virus-specific CTLs was low and increased slowly. These results indicate that expression of LIR-1 increases during differentiation of virus-specific CD8+ effector T cells. Furthermore, they suggest that a potential immunoregulatory function of UL18 may be to preferentially target highly differentiated HCMV-specific effector memory T cells during persistent infection.


PLOS ONE | 2016

PD-1 expression and cytokine secretion profiles of Mycobacterium tuberculosis-specific CD4+ T-cell subsets; potential correlates of containment in HIV-TB co-infection

Katrina Pollock; Damien Montamat-Sicotte; Lisa Grass; Graham S. Cooke; Moses S. Kapembwa; Onn Min Kon; Robert D. Sampson; Graham P. Taylor; Ajit Lalvani

HIV co-infection is an important risk factor for tuberculosis (TB) providing a powerful model in which to dissect out defective, protective and dysfunctional Mycobacterium tuberculosis (MTB)-specific immune responses. To identify the changes induced by HIV co-infection we compared MTB-specific CD4+ responses in subjects with active TB and latent TB infection (LTBI), with and without HIV co-infection. CD4+ T-cell subsets producing interferon-gamma (IFN-γ), interleukin-2 (IL-2) and tumour necrosis factor-alpha (TNF-α) and expressing CD279 (PD-1) were measured using polychromatic flow-cytometry. HIV-TB co-infection was consistently and independently associated with a reduced frequency of CD4+ IFN-γ and IL-2-dual secreting T-cells and the proportion correlated inversely with HIV viral load (VL). The impact of HIV co-infection on this key MTB-specific T-cell subset identifies them as a potential correlate of mycobacterial immune containment. The percentage of MTB-specific IFN-γ-secreting T-cell subsets that expressed PD-1 was increased in active TB with HIV co-infection and correlated with VL. This identifies a novel correlate of dysregulated immunity to MTB, which may in part explain the paucity of inflammatory response in the face of mycobacterial dissemination that characterizes active TB with HIV co-infection.


BMJ Open | 2012

Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study

Katrina Pollock; Herman Tam; Lisa Grass; Sharleen Bowes; Graham S. Cooke; Manish Pareek; Damien Montamat-Sicotte; Moses S. Kapembwa; Graham P. Taylor; Ajit Lalvani

Background HIV is the most important risk factor for progression of latent tuberculosis infection (LTBI) to active tuberculosis (TB). Detection and treatment of LTBI is necessary to reduce the increasing burden of TB in the UK, but a unified LTBI screening approach has not been adopted. Objective To compare the effectiveness of a TB risk-focused approach to LTBI screening in the HIV-positive population against current UK National Institute for Health and Clinical Excellence (NICE) guidance. Design Prospective cohort study. Setting Two urban HIV treatment centres in London, UK. Participants 114 HIV-infected individuals with defined TB risk factors were enrolled prospectively as part of ongoing studies into HIV and TB co-infection. Outcome measures The yield and case detection rate of LTBI cases within the research study were compared with those generated by the NICE criteria. Results 17/114 (14.9%, 95% CI 8.3 to 21.5) had evidence of LTBI. Limiting screening to those meeting NICE criteria for the general population (n=43) would have detected just over half of these, 9/43 (20.9%, 95% CI 8.3 to 33.5) and those meeting criteria for HIV co-infection (n=74) would only have captured 8/74(10.8%, 95% CI 3.6 to 18.1) cases. The case detection rates from the study and NICE approaches were not significantly different. LTBI was associated with the presence of multiple TB risk factors (p=0.002). Conclusion Adoption of a TB risk-focused screening algorithm that does not use CD4 count stratification could prevent more cases of TB reactivation, without changing the case detection rate. These findings should be used to inform a large-scale study to create unified guidelines.


Immunity, inflammation and disease | 2015

Differences in antigen-specific CD4+ responses to opportunistic infections in HIV infection

Katrina Pollock; Damien Montamat-Sicotte; Graham S. Cooke; Moses S. Kapembwa; Onn Min Kon; Lisa Grass; Robert D. Sampson; Graham P. Taylor; Ajit Lalvani

HIV‐infected individuals with severe immunodeficiency are at risk of opportunistic infection (OI). Tuberculosis (TB) may occur without substantial immune suppression suggesting an early and sustained adverse impact of HIV on Mycobacterium tuberculosis (MTB)‐specific cell mediated immunity (CMI). This prospective observational cohort study aimed to observe differences in OI‐specific and MTB‐specific CMI that might underlie this. Using polychromatic flow cytometry, we compared CD4+ responses to MTB, cytomegalovirus (CMV), Epstein‐Barr virus (EBV) and Candida albicans in individuals with and without HIV infection. MTB‐specific CD4+ T‐cells were more polyfunctional than virus specific (CMV/EBV) CD4+ T‐cells which predominantly secreted IFN‐gamma (IFN‐γ) only. There was a reduced frequency of IFN‐γ and IL‐2 (IL‐2)‐dual‐MTB‐specific cells in HIV‐infected individuals, which was not apparent for the other pathogens. MTB‐specific cells were less differentiated especially compared with CMV‐specific cells. CD127 expression was relatively less frequent on MTB‐specific cells in HIV co‐infection. MTB‐specific CD4+ T‐cells PD‐1 expression was infrequent in contrast to EBV‐specific CD4+ T‐cells. The variation in the inherent quality of these CD4+ T‐cell responses and impact of HIV co‐infection may contribute to the timing of co‐infectious diseases in HIV infection.


Viral Immunology | 2005

Expression of Leukocyte Immunoglobulin-Like Receptors and Natural Killer Receptors on Virus-Specific CD8+ T Cells during the Evolution of Epstein-Barr Virus-Specific Immune Responses in Vivo

Kathryn Poon; Damien Montamat-Sicotte; Nicole Cumberbatch; Andrew J. McMichael; Margaret F. C. Callan


Natural Product Communications | 2011

Antiprotozoal, Antitubercular and Cytotoxic Potential of Cyanobacterial (Blue-Green Algal) Extracts from Ireland

Barbara Broniatowska; Andrea Allmendinger; Marcel Kaiser; Damien Montamat-Sicotte; Suzie Hingley-Wilson; Ajit Lalvani; Michael D. Guiry; Gerald Blunden; Deniz Tasdemir

Collaboration


Dive into the Damien Montamat-Sicotte's collaboration.

Top Co-Authors

Avatar

Ajit Lalvani

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Onn Min Kon

Imperial College Healthcare

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Katrina Pollock

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Lisa Grass

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Robert D. Sampson

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge